Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Decoy Therapeutics Inc. DCOY US Equity

Health Care · CIK 1615219 · FY ends Dec 31
$2.97
-0.04 (-1.33%)
USD · as of 2026-08-27 · marketstack

Decoy Therapeutics Inc. (Nasdaq: DCOY), an SEC filer in Pharmaceutical Preparations, closed at $2.97, -1.3%, on 2026-08-27, with a market cap of $2M and a return on equity of -338.3%. Institutional ownership, earnings history and filed financials are on the tabs below.

Short interest· FINRA consolidated · settlement 2026-08-14

6 settlement cycles
Shares short11K
% of shares out1.6%
Days to cover1.0
Δ vs 2026-07-31-57.7%
▲ 156K shares shortline top = 1.0d to cover2026-05-29: 9K short · 1.0d to cover2026-052026-06-15: 2K short · 1.0d to cover2026-062026-06-30: 156K short · 1.0d to cover2026-062026-07-15: 24K short · 1.0d to cover2026-072026-07-31: 25K short · 1.0d to cover2026-072026-08-14: 11K short · 1.0d to cover2026-08

bars = shares short · line = days to cover (own scale)

SettlementShares shortΔ vs priorAvg daily volumeDays to cover
2026-08-1410,675-57.7%34,1211.0
2026-07-3125,246+5.3%107,8831.0
2026-07-1523,986-84.7%44,8631.0
2026-06-30156,313+7850.8%1,217,6471.0
2026-06-151,966-78.5%18,5361.0
2026-05-299,158+7.6%14,8981.0

FINRA Rule 4560 · twice monthly, published ~a week later.

Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.